Parkinson's disease
Centogene Strikes Deals With Premier Research, Denali Therapeutics for Clinical Trials
Centogene will work with Premier to offer rare disease clinical trial support services and has extended a Parkinson's disease-focused alliance with Denali.
Parkinson's Foundation Taps Tag.bio for PD GENEration Data Sharing, Analysis
The foundation will use Tag.bio's software to link anonymized clinical and genomic datasets to research Parkinson's disease causes and personalized treatment.
Metabolon, Parkinson's UK Form Biomarker Discovery Alliance
Metabolon will participate in a Parkinson's UK-funded study to map metabolic changes in serum that can serve as biomarkers of disease progression.
Qiagen, Neuron23 Partner for NGS-Based Parkinson's Disease Companion Diagnostic
The collaboration will expand Qiagen's NGS testing portfolio for precision medicine beyond oncology into neurology applications.
Twenty-three out of 50 planned study sites are now active, and a partnership with Morehouse School of Medicine will help with minority recruitment.